Bristol Myers Squibb

Bristol-Myers Squibb (BMY) Q4 2025 Earnings Call Transcript

Bristol-Myers Squibb (BMY) Q4 2025 Earnings Call Transcript

By
February 5, 2026
Bristol-Myers Squibb (BMY) Q3 2025 Earnings Call Transcript

Bristol-Myers Squibb (BMY) Q3 2025 Earnings Call Transcript

By
October 30, 2025
Bristol-Myers Squibb (BMY) Q2 2025 Earnings Call Transcript

Bristol-Myers Squibb (BMY) Q2 2025 Earnings Call Transcript

By
July 31, 2025
Bristol-Myers Squibb (BMY) Q1 2025 Earnings Call Transcript

Bristol-Myers Squibb (BMY) Q1 2025 Earnings Call Transcript

By
April 24, 2025
Bristol-Myers Squibb (BMY) Q4 2024 Earnings Call Transcript

Bristol-Myers Squibb (BMY) Q4 2024 Earnings Call Transcript

By
February 6, 2025
Brainstorm Health 2020-Giovanni Caforio-Vas Narasimhan
Conferences

Will the pharmaceutical industry keep collaborating after COVID-19? Novartis and Bristol Myers Squibb CEOs say it has to

By
July 7, 2020
5 companies to keep an eye on following the world’s largest cancer conference
Health

5 companies to keep an eye on following the world’s largest cancer conference

By
June 3, 2020
Fitbit BMS Pfizer AFib
Newsletters

Fitbit Teams Up With Drug Giants to Tackle a Serious Heart Condition: Brainstorm Health

By
October 17, 2019
FDA drug approvals Roche Celgene AbbVie
Newsletters

The FDA Went on an Epic Drug Approval Binge This Week: Brainstorm Health

By
August 16, 2019
BMS Celgene acquisition
Health

Bristol-Myers Squibb Loses $6 Billion in Value on Celgene Deal Setback: Brainstorm Health

By
June 24, 2019
Laboratory for production of cancer drug

Bristol-Myers Is Buying Celgene for $74 Billion in One of the Largest Big Pharma Mergers Ever

By
January 3, 2019
CHINA-ECONOMY-CREDI-LOANS-DEBT-GOVERNMENT
Health

A Cancer Blockbuster Gets Approved in China. Will the Floodgates Now Open?

By
June 15, 2018
Lung cancer on the left pulmonary lobe, seen on a frontal X-ray of the chest.
Health

Merck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer

By
April 16, 2018
This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring
Health

This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring

By
April 9, 2018
US-ECONOMY-STOCK MARKET
Health

Why Cancer Drug Maker Incyte’s Stock Plunged—And Took Others Down With It

By
April 6, 2018

Most Popular